1. Gertz MA, Terpos E, Dispenzieri A, et al. Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents. Leuk Lymphoma. 2015; 56:1723–1726. PMID:
25284489.
Article
2. Pemmaraju N, Shah D, Kantarjian H, et al. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015; 15:110–114. PMID:
25107338.
Article
3. Reddi DM, Lu CM, Fedoriw G, et al. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens. Am J Clin Pathol. 2012; 138:855–866. PMID:
23161720.
4. Malhotra J, Kremyanskaya M, Schorr E, Hoffman R, Mascarenhas J. Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia. Clin Lymphoma Myeloma Leuk. 2014; 14:31–36. PMID:
24220620.
Article
5. Várkonyi J, Jánosy J, Gopcsa L, et al. Myelodysplasia and multiple myeloma or monoclonal gammopathy. A non-fortuitous coexistence. Hungarian Med J. 2007; 1:107–112.
Article
6. Tsiara S, Economou G, Panteli A, Isaakidis P, Kapsali E, Bourantas KL. Coexistence of myelodysplastic syndrome and multiple myeloma. J Exp Clin Cancer Res. 1999; 18:565–566. PMID:
10746986.
7. Yoshida Y, Oguma S, Ohno H, et al. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases. Int J Hematol. 2014; 99:721–725. PMID:
24687918.
Article